The study demonstrated that MOTS-c levels in the blood of centenarians, individuals who have survived to 100 years and older, were significantly higher than in age-matched individuals with shorter lifespans, and resembled levels seen in much younger adults [2]
A 2025 safety study confirmed that IV BPC-157 was well tolerated in healthy adults with no adverse events
When GHK-Cu activates its pathways, it is simultaneously building new structural tissue, accelerating the removal of damaged tissue, and suppressing the inflammatory environment that would otherwise slow both of those processes
The benefits claimedreversal of aging, improved cognition, enhanced metabolismremain unproven in controlled human trials
Developed by Novo Nordisk, CagriSema is a combination medication of cagrilintide and the GLP-1 receptor agonist semaglutide